4KN-23730-79768
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 605 / IL
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Moderna
-
2021-01-26
Dose 2 — Moderna
-
2021-01-29
Registered in v-safe
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Fatigue, Nausea, Pain in extremity — Feeling: Good · Site: Pain · Be unable to workFree text: Day after second dose had sore arm, 100 degrees temperature, severe nausea, chills, and fatigue for 24 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
- 2021-01-30
- 2021-07-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-29 | priority 2/3 |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Day after second dose had sore arm, 100 degrees temperature, severe nausea, chills, and fatigue for 24 hours
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release